Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons

Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in... 1 The striatum is a crucial site of action for the motor effects of cannabinoids (CBs). However, the electrophysiological consequences of activation of CB receptors on the striatal neurons have not been established. Here we report for the first time that the cannabimimetic aminoalkylindole WIN 55,212‐2 and the endogenous cannabinoid anandamide substantially depress corticostriatal glutamatergic synaptic transmission onto striatal neurons in the brain slice preparation. The selective CB1 receptor antagonist SR 141716 effectively reversed this inhibition. 2 WIN 55,212‐2 significantly increased the paired‐pulse facilitation of synaptically evoked EPSCs, while having no effect on the sensitivity of postsynaptic neurons to α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid. WIN 55,212‐2 also reduced the frequency of spontaneous, action potential‐dependent EPSCs (sEPSCs) without altering their amplitude distribution. 3 Superfusion of WIN 55,212‐2 elicited a membrane hyperpolarization accompanied by a decrease in input resistance. Both effects were blocked by intracellular caesium. In contrast, intracellular caesium failed to affect WIN 55,212‐2‐mediated synaptic inhibition. 4 The WIN 55,212‐2‐mediated synaptic inhibition was blocked by the Gi/o protein inhibitor pertussis toxin (PTX), but not by the GABAA receptor antagonist bicuculline or GABAB receptor antagonist SCH 50911. 5 Pretreatment with the N‐type Ca2+ channel antagonist ω‐conotoxin GVIA selectively abolished the WIN‐55,212‐2‐mediated synaptic inhibition. 6 These results suggest that cannabinoids depress the corticostriatal glutamatergic synaptic transmission through the activation of presynaptic CB1 receptors to inhibit N‐type Ca2+ channel activity, which in turn reduces glutamate release. The presynaptic action of cannabinoids is mediated by a PTX‐sensitive Gi/o protein‐coupled signalling pathway. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Physiology Wiley

Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons

Download PDF
18 pages
Read Article

Loading next page...
 
/lp/wiley/presynaptic-mechanisms-underlying-cannabinoid-inhibition-of-excitatory-BamGLXlVwB
Publisher
Wiley
Copyright
Copyright © 2001 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0022-3751
eISSN
1469-7793
DOI
10.1111/j.1469-7793.2001.0731e.x
Publisher site
See Article on Publisher Site

Abstract

1 The striatum is a crucial site of action for the motor effects of cannabinoids (CBs). However, the electrophysiological consequences of activation of CB receptors on the striatal neurons have not been established. Here we report for the first time that the cannabimimetic aminoalkylindole WIN 55,212‐2 and the endogenous cannabinoid anandamide substantially depress corticostriatal glutamatergic synaptic transmission onto striatal neurons in the brain slice preparation. The selective CB1 receptor antagonist SR 141716 effectively reversed this inhibition. 2 WIN 55,212‐2 significantly increased the paired‐pulse facilitation of synaptically evoked EPSCs, while having no effect on the sensitivity of postsynaptic neurons to α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid. WIN 55,212‐2 also reduced the frequency of spontaneous, action potential‐dependent EPSCs (sEPSCs) without altering their amplitude distribution. 3 Superfusion of WIN 55,212‐2 elicited a membrane hyperpolarization accompanied by a decrease in input resistance. Both effects were blocked by intracellular caesium. In contrast, intracellular caesium failed to affect WIN 55,212‐2‐mediated synaptic inhibition. 4 The WIN 55,212‐2‐mediated synaptic inhibition was blocked by the Gi/o protein inhibitor pertussis toxin (PTX), but not by the GABAA receptor antagonist bicuculline or GABAB receptor antagonist SCH 50911. 5 Pretreatment with the N‐type Ca2+ channel antagonist ω‐conotoxin GVIA selectively abolished the WIN‐55,212‐2‐mediated synaptic inhibition. 6 These results suggest that cannabinoids depress the corticostriatal glutamatergic synaptic transmission through the activation of presynaptic CB1 receptors to inhibit N‐type Ca2+ channel activity, which in turn reduces glutamate release. The presynaptic action of cannabinoids is mediated by a PTX‐sensitive Gi/o protein‐coupled signalling pathway.

Journal

The Journal of Physiology – Wiley

Published: May 1, 2001

References

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial